VITAL THERAPIES INC Human Resources Contracts & Agreements

31 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (8 contracts)
Change of Control Agreements (2)
Compensation Agreements (4)
Employment Agreements (15)
Severance Agreements (1)
Transition Agreements (1)

Recent Contracts

Addendum No. 6, dated August 29, 2024, to Employment Agreement, dated April 17, 2020, between Immunic, Inc. and Duane Nash (Filed With SEC on September 3, 2024)
Employment Agreement, dated December 18, 2023, between Immunic, Inc. and Dr. Andreas Muehler (Filed With SEC on December 21, 2023)
Addendum No. 5, dated October 17, 2023, to Employment Agreement, dated April 17, 2020, between Immunic, Inc. and Duane Nash (Filed With SEC on October 18, 2023)
Addendum No. 4 to Employment Agreement, dated December 28, 2022, between Immunic, Inc. and Duane Nash (Filed With SEC on December 30, 2022)
Addendum No. 3 to Employment Agreement, dated March 15, 2022, between Immunic, Inc. and Duane Nash (Filed With SEC on March 16, 2022)
Employment Agreement, dated October 14, 2021, by Patrick Walsh and Immunic, Inc (Filed With SEC on October 15, 2021)
Employment Agreement, dated June 10, 2021, between Immunic, Inc. and Glenn Whaley (Filed With SEC on June 14, 2021)
Employment Agreement, dated June 10, 2021, between Immunic, Inc. and Dr. Andreas Muehler (Filed With SEC on June 14, 2021)
Addendum No. 2 to Employment Agreement, dated April 15, 2021, between Immunic, Inc. and Duane Nash (Filed With SEC on April 19, 2021)
Addendum to Employment Agreement dated October 15, 2020, between Immunic, Inc. and Duane Nash (Filed With SEC on November 6, 2020)
Employment Agreement dated April 17, 2020 (Filed With SEC on April 20, 2020)
Confidential Severance Agreement and Full and General Release dated April 17, 2020 (Filed With SEC on April 20, 2020)
Grppel Employment Agreement, dated as of August 26, 2016, by and between Dr. Manfred Grppel and Immunic AG (Filed With SEC on July 17, 2019)
Vitt Employment Agreement, dated as of March 23, 2016, by and between Dr. Daniel Vitt and Immunic AG (Filed With SEC on July 17, 2019)
Employment Agreement, dated as of July 15, 2019, by and between Sanjay Patel and Immunic, Inc (Filed With SEC on July 17, 2019)
Form of Amendment No. 1 to Change of Control and Severance Agreement (Filed With SEC on January 14, 2019)
Form of RSU Award Agreement under 2014 Equity Incentive Plan (Filed With SEC on January 14, 2019)
Amended Global Stock Option Agreement under 2014 Equity Incentive Plan (Filed With SEC on March 13, 2018)
Employment Letter Agreement between the Registrant and Russel J. Cox, dated November 30, 2017 (Filed With SEC on March 13, 2018)
Transition Agreement and Release between the Registrant and Terence E. Winters, dated December 4, 2017 (Filed With SEC on March 13, 2018)
U.S. Stock Option Agreement under 2017 Inducement Equity Incentive Plan (Filed With SEC on October 25, 2017)
2017 Inducement Equity Incentive Plan (Filed With SEC on October 25, 2017)
VITAL THERAPIES, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Adopted and approved May 13, 2013 As Amended March 18, 2015, December 18, 2015 and May 24, 2016 (Filed With SEC on May 27, 2016)
VITAL THERAPIES, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Adopted and approved May 13, 2013 As Amended March 18, 2015 and December 18, 2015 (Filed With SEC on March 8, 2016)
VITAL THERAPIES, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Adopted and approved May 13, 2013 As Amended March 18, 2015 (Filed With SEC on May 12, 2015)
VITAL THERAPIES, INC. 2014 EQUITY INCENTIVE PLAN GLOBAL STOCK OPTION AGREEMENT (Filed With SEC on March 20, 2015)
VITAL THERAPIES, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on March 11, 2014)
VITAL THERAPIES, INC. Non-Employee Director Compensation Policy (Filed With SEC on November 15, 2013)
VITAL THERAPIES, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on November 6, 2013)
VITAL THERAPIES, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on October 11, 2013)
VITAL THERAPIES, INC. EXECUTIVE INCENTIVE COMPENSATION PLAN Adopted by the Board of Directors on July 8, 2013 (Filed With SEC on October 11, 2013)